CTIBiotech
PrivateLast Round
Corporate Funding
May 4, 2026
Total Funding Raised
$1.35M
Momentum Score
25 /100
Company Overview
CTIBiotech is a biotechnology company that specializes in 3D bioprinting and advanced human tissue engineering, providing predictive bioassays and contract research services as an alternative to animal testing.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CTIBiotech Comps
Public and private peers based on sector, stage, and business model.
CTIBiotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | May 4, 2026 | ||||
| Grant | Apr 28, 2026 |
CTIBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| France 2030 | Grant |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 4, 2026
Raised $27M in corporate funding.
- Apr 28, 2026
$1.35M grant received from Bpifrance and France 2030.
CTIBiotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CTIBiotech's valuation, stock price, and market status.
